EFFECT OF URINE PH AND FLOW ON RENAL CLEARANCE OF METHOTREXATE

被引：69
作者：
SAND, TE
JACOBSEN, S
机构：
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1981年 / 19卷 / 06期
关键词：
D O I：
10.1007/BF00548590
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：453 / 456
页数：4
相关论文
共 17 条
[1]  
BLOOMER HA, 1966, J LAB CLIN MED, V67, P898
[2]  
DETTLI L, 1976, CLIN PHARMACOKINET, V1, P81
[3]  
DJERASSI I, 1976, CANCER, V38, P1043, DOI 10.1002/1097-0142(197609)38:3<1043::AID-CNCR2820380302>3.0.CO
[4]  
2-U
[5]  
GIBALDI M, DRUGS PHARMACEUTICAL, V1
[6]  
GORNALL AG, 1949, J BIOL CHEM, V177, P751
[7]   ADJUVANT METHOTREXATE AND CITROVORUM-FACTOR TREATMENT OF OSTEOGENIC SARCOMA [J].
JAFFE, N ;
FREI, E ;
TRAGGIS, D ;
BISHOP, Y .
NEW ENGLAND JOURNAL OF MEDICINE, 1974, 291 (19) :994-997
[8]   RAPID, RADIOCHEMICAL LIGAND BINDING ASSAY FOR METHOTREXATE [J].
KAMEN, BA ;
TAKACH, PL ;
VATEV, R ;
CASTON, JD .
ANALYTICAL BIOCHEMISTRY, 1976, 70 (01) :54-63
[9]  
LEVITT M, 1973, CANCER RES, V33, P1729
[10]   BINDING OF QUINIDINE TO PROTEIN-FRACTIONS OF NORMAL HUMAN SERA [J].
NILSEN, OG ;
JACOBSEN, S .
BIOCHEMICAL PHARMACOLOGY, 1975, 24 (09) :995-998
12